Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

<h3>Background</h3><p dir="ltr">Despite decades of intensive research, to date, there is no accepted diagnosis for Parkinson’s disease (PD) based on biochemical analysis of blood or CSF. However, neurodegeneration in the brains of PD patients begins several years before t...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Nour K. Majbour (8809316) (author)
مؤلفون آخرون: Nishant N. Vaikath (2901785) (author), Karin D. van Dijk (18891685) (author), Mustafa T. Ardah (4858657) (author), Shiji Varghese (291775) (author), Louise B. Vesterager (19738231) (author), Liliana P. Montezinho (19738234) (author), Stephen Poole (607442) (author), Bared Safieh-Garabedian (3554684) (author), Takahiko Tokuda (105837) (author), Charlotte E. Teunissen (7830647) (author), Henk W. Berendse (8809328) (author), Wilma D. J. van de Berg (8809325) (author), Omar M. A. El-Agnaf (8809331) (author)
منشور في: 2016
الموضوعات:
Biomedical and clinical sciences
Neurosciences
Parkinson’s disease
Alpha synuclein
Cerebrospinal fluid biomarkers
Amyloid oligomers
Biomarkers
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة